Research article Special Issues

A synthesized model of tuberculosis transmission featuring treatment abandonment


  • In this paper, we propose and justify a synthesized version of the tuberculosis transmission model featuring treatment abandonment. In contrast to other models that account for the treatment abandonment, our model has only four state variables or classes (susceptible, latent, infectious, and treated), while people abandoning treatment are not gathered into an additional class. The proposed model retains the core properties that are highly desirable in epidemiological modeling. Namely, the disease transmission dynamics is characterized by the basic reproduction number R0, a threshold value that determines the number of possible steady states and their stability properties. It is shown that the disease-free equilibrium is globally asymptotically stable (GAS) only if R0<1, while a strictly positive endemic equilibrium exists and is GAS only if R0>1. Analysis of the dependence of R0 on the treatment abandonment rate shows that a reduction of the treatment abandonment rate has a positive effect on the disease incidence and results in avoiding disease-related fatalities.

    Citation: Edwin Barrios-Rivera, Hanner E. Bastidas-Santacruz, Carmen A. Ramirez-Bernate, Olga Vasilieva. A synthesized model of tuberculosis transmission featuring treatment abandonment[J]. Mathematical Biosciences and Engineering, 2022, 19(11): 10882-10914. doi: 10.3934/mbe.2022509

    Related Papers:

    [1] Na Pang . Nonlinear neural networks adaptive control for a class of fractional-order tuberculosis model. Mathematical Biosciences and Engineering, 2023, 20(6): 10464-10478. doi: 10.3934/mbe.2023461
    [2] Shanjing Ren . Global stability in a tuberculosis model of imperfect treatment with age-dependent latency and relapse. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1337-1360. doi: 10.3934/mbe.2017069
    [3] Georgi Kapitanov . A double age-structured model of the co-infection of tuberculosis and HIV. Mathematical Biosciences and Engineering, 2015, 12(1): 23-40. doi: 10.3934/mbe.2015.12.23
    [4] Silvia Martorano Raimundo, Hyun Mo Yang, Ezio Venturino . Theoretical assessment of the relative incidences of sensitive andresistant tuberculosis epidemic in presence of drug treatment. Mathematical Biosciences and Engineering, 2014, 11(4): 971-993. doi: 10.3934/mbe.2014.11.971
    [5] Abba B. Gumel, Baojun Song . Existence of multiple-stable equilibria for a multi-drug-resistant model of mycobacterium tuberculosis. Mathematical Biosciences and Engineering, 2008, 5(3): 437-455. doi: 10.3934/mbe.2008.5.437
    [6] C. Connell McCluskey . Global stability for an SEI epidemiological model with continuous age-structure in the exposed and infectious classes. Mathematical Biosciences and Engineering, 2012, 9(4): 819-841. doi: 10.3934/mbe.2012.9.819
    [7] Tao-Li Kang, Hai-Feng Huo, Hong Xiang . Dynamics and optimal control of tuberculosis model with the combined effects of vaccination, treatment and contaminated environments. Mathematical Biosciences and Engineering, 2024, 21(4): 5308-5334. doi: 10.3934/mbe.2024234
    [8] Juan Pablo Aparicio, Carlos Castillo-Chávez . Mathematical modelling of tuberculosis epidemics. Mathematical Biosciences and Engineering, 2009, 6(2): 209-237. doi: 10.3934/mbe.2009.6.209
    [9] Xi-Chao Duan, Xue-Zhi Li, Maia Martcheva . Dynamics of an age-structured heroin transmission model with vaccination and treatment. Mathematical Biosciences and Engineering, 2019, 16(1): 397-420. doi: 10.3934/mbe.2019019
    [10] Surabhi Pandey, Ezio Venturino . A TB model: Is disease eradication possible in India?. Mathematical Biosciences and Engineering, 2018, 15(1): 233-254. doi: 10.3934/mbe.2018010
  • In this paper, we propose and justify a synthesized version of the tuberculosis transmission model featuring treatment abandonment. In contrast to other models that account for the treatment abandonment, our model has only four state variables or classes (susceptible, latent, infectious, and treated), while people abandoning treatment are not gathered into an additional class. The proposed model retains the core properties that are highly desirable in epidemiological modeling. Namely, the disease transmission dynamics is characterized by the basic reproduction number R0, a threshold value that determines the number of possible steady states and their stability properties. It is shown that the disease-free equilibrium is globally asymptotically stable (GAS) only if R0<1, while a strictly positive endemic equilibrium exists and is GAS only if R0>1. Analysis of the dependence of R0 on the treatment abandonment rate shows that a reduction of the treatment abandonment rate has a positive effect on the disease incidence and results in avoiding disease-related fatalities.



    Pulmonary tuberculosis (TB) is a public health problem in many countries worldwide and constitutes one of the leading causes of morbidity and mortality. This infectious disease puts a large number of people with weakened immune systems at risk, for example, due to the HIV/AIDS or diabetes comorbidities, chemo/radio-therapies, transplants, or malnutrition. Also, tuberculosis is a social disease that mainly affects poor people living in crowded and precarious conditions of big cities or penitentiary institutions, especially in low- and middle-income countries [1, 2].

    Tuberculosis is caused by a species of pathogenic bacteria called mycobacterium tuberculosis or Koch's bacilli. The bacteria can attack any part of the body, but usually attack the lungs. This disease is transmitted from person to person through microscopic airborne droplets from the cough or sneeze of a person with an active form of the disease. Thus, a susceptible person can become infected by inhaling airborne bacilli. Common symptoms of active pulmonary tuberculosis are severe cough (often with blood in the sputum), chest pain, weakness, fever, poor appetite, and weight loss.

    However, people who are infected with TB do not always feel sick. The World Health Organization [3] estimates that a quarter of the world's population has tuberculosis in a "latent" or inactive form; that is, these people are carriers of inactive bacilli, they have no symptoms of the disease, and they cannot transmit the infection to others. However, inactive bacilli can regain their vitality together with replication capacity and cause an active form of the disease when the immune response of a latent person is disturbed or altered.

    A noticeable epidemiological feature of tuberculosis is its long period of latency that may last from several weeks to a lifetime. On the one hand, people with a latent form of tuberculosis can last in this state for many years without actively developing the disease, as long as their immune system does not present alterations. On the other hand, latent people whose immune systems are weakened due to malnutrition or comorbidities (influenza, pneumonia, COVID19, kidney disease, diabetes, etc.) or those receiving immunosuppressive treatments for HIV, cancer, or transplants are at much higher risk of developing an active form of tuberculosis.

    The active form of tuberculosis can be diagnosed with the sputum smear test (also known as acid fast bacillus testing—AFB+) that detects the presence of active bacilli, whereas the latent form of tuberculosis can be detected by the tuberculin skin test or the measurement of interferon-γ in whole blood (also known as interferon-gamma release assays—IGRAs) [4]. Both forms of tuberculosis are treatable by antibiotics, although the treatment periods are rather long (6–12 months) and require prolonged medical monitoring [5].

    Most patients may recover from a primary active TB infection without further manifestation of the disease if they strictly follow all the guidelines of medical treatment. Even though the drugs that are widely used nowadays for standard TB treatment (namely, isoniazid and rifampicin) are nominally characterized as "sterilizing", several studies question this characterization and manifest that a patient does not always achieve true sterilization after completing treatment [6, 7]. Besides, total bacilli extermination cannot be reliably confirmed by existing test methods, such as blood and sputum markers [8].

    Moreover, low- and middle-income countries lack the infrastructure, funding, or capacity to diagnose and treat patients with the latent form of tuberculosis. Therefore, TB control in these countries is centered on preventing latent TB infections from developing into active disease and on diagnosing and treating patients with the active form of the disease [9, 10].

    Several studies (see e.g., [11, 12] and references therein) pointed out that treatment non-adherence and abandonment mostly occurs due to the patient-related factors (such as low income, unemployment, illiteracy), to the health services (reduced availability, intermittent access, and bureaucratic structure), and to the characteristics of the treatment itself (long duration and possible adverse effects). To prevent the spread of the contagious (or active) form of the disease it is important to ensure that all patients take their anti-tuberculosis medications exactly as prescribed and do not abandon the treatment before its full completion. Notably, the patients who do not follow the strict guidelines for treatment or those who abandon treatment before completion usually remain infectious and develop the so-called "drug-resistant" form of active tuberculosis. Moreover, people with active TB not receiving proper medical treatment may die from this infectious disease.

    This paper aims to propose and analyze a lower-dimensional model of TB transmission that accounts for treatment abandonment. Among a wide variety of mathematical models describing the dynamics of tuberculosis transmission, there are only a few that are deliberately kept mathematically tractable and apt for theoretical analysis*. The prime feature of such compartmental models is the relatively small number of state variables (four or fewer) that denote the disjoint classes compounding the target human population. In particular, there are several models where the human population is defined by the sum of four classes or compartments [14, 15, 16, 17, 18]: Susceptible and latently infected people (they are non-infectious), actively infected people (they are fully infectious), and people undergoing treatment (they are partially infectious). However, these models do not account for patients who abandon the treatment before its completion while the treatment abandonment enhances the disease spread.

    *A more detailed survey of simplest models describing the transmission of tuberculosis has been performed in [13].

    On the other hand, more sophisticated models of higher dimension where all individuals who abandon treatment are gathered in an additional class or compartment have been proposed and studied during the last decade [19, 20, 21, 22, 23]. These and, possibly, other studies have disclosed through mathematical modeling the adverse effects of treatment abandonment on the disease persistence and spread.

    It is worth mentioning that the four-dimensional model presented in [24] includes two classes of infectious people, those who receive treatment (partially infectious) and those who refuse ("lost to follow up" cases or fully infectious), along with susceptible and latent classes (non-infectious). This is an interesting formulation though it is based on a strong assumption that does not seem realistic. Namely, all individuals are timely identified as latently or actively infected, then they are immediately offered to start treatment, and then they either accept or refuse that offer. In other words, people with identified TB infections either start being treated or become "lost to follow up" cases without starting treatment. In contrast to the model presented in [24], the model proposed in this work assumes that all identified carriers of the active bacilli start being treated. Afterward, they either complete the treatment and become non-infectious or abandon the treatment before completion and become infectious.

    The proposed model is presented in Section 2, while its basic reproductive number and its possible equilibria are derived in Section 3. Section 4 is centered on establishing the properties of global stability for two possible equilibria of the proposed model. The role of the treatment abandonment rate is then illustrated in Section 5 by examining two scenarios, with and without treatment abandonment. Finally, Section 6 provides conclusions of our work.

    In this section, we propose a four-dimensional model that incorporates a group of people with an active form of the disease, who start the anti-tuberculosis treatment and then quit without completing it. The distinctive feature of this model is that such people are not separated into an additional class. Thus, our model has only four state variables, namely:

    S(t) – the number of susceptible individuals at the moment t0 who are bacillus-free.

    L(t) – the number of latently infected individuals at the moment t0 who are carriers of inactive bacilli but they have no symptoms of the disease and cannot transmit it to the others (i.e., they are non-infectious).

    I(t) – the number of actively infected individuals at the moment t0 who have not commenced the treatment yet; they are carriers of active bacilli, have symptoms of the disease, and are fully capable of transmitting it to the others (i.e., they are fully infectious).

    T(t) – the number of individuals undergoing treatment at the moment t0; they are carriers of active bacilli but their infectiousness is reduced by the treatment (i.e., they are partially infectious).

    In this model, we assume that all four classes are homogeneously mixed and the disease transmission depends on the frequency of respiratory contacts between the bacillus-free individuals and those carrying active bacilli.

    Thus, the total population at each moment t0 denoted by

    N(t):=S(t)+L(t)+I(t)+T(t). (2.1)

    The interaction between four disjoint classes S(t),L(t),I(t), and T(t) is described by the following ODE system

    {dSdt=Λβ(I+ϕT)SμS(2.2a)dLdt=(1p)β(I+ϕT)S+δTϵLμL(2.2b)dIdt=pβ(I+ϕT)S+ϵL+kTγIαIμI(2.2c)dTdt=γIδTkTμT(2.2d)

    with nonnegative initial conditions

    S(0)=S0,L(0)=L0,I(0)=I0,T(0)=T0. (2.3)

    It is assumed that all newborn individuals are bacillus-free, they belong to the S-class, and they are recruited at the constant rate Λ>0 (see Eq (2.2a) above). Notably, even though the immunological changes during pregnancy may activate the TB infection in pregnant women with the latent form of the disease, there is no evidence of TB vertical transmission [25]. The average rate of natural mortality of all human individuals is denoted by μ>0.

    The disease transmission is modeled by the mass action incidence through the term β(I+ϕT) in Eqs (2.2a)–(2.2c). Here, β>0 denotes the so-called per capita rate of effective respiratory contacts with infectious people (i.e., those leading to the contagion) and can be viewed as

    β(No.ofcontactsperpersonperunittime)×(probabilityofcontagion)Totalpopulationsize(Λ/μ).

    When a susceptible person inhales active bacilli, he/she may either develop an active form of the disease with probability p(0,1) or progress to the class of latently infected people L(t) with probability (1p) (cf. the first terms in Eqs (2.2b)–(2.2c)). The probability p of developing an active form of the disease is related to the immune status of the human host that receives active bacilli. Thus, people with a weakened immune response due to comorbidities (influenza, pneumonia, COVID19, kidney disease, diabetes, etc.), malnutrition, or immunosuppressive treatments for HIV, cancer, or transplants are at much higher risk of developing an active form of tuberculosis.

    Susceptible people may become infected through respiratory contacts with either fully infectious people (from the class I(t)) or partially infectious people (from the class T(t)). It has been shown that treatment reduces, but does not fully eliminate, the infectiousness of patients with active forms of tuberculosis [26]. Therefore, our model (2.2) assumes that people from the T-class are capable of transmitting the disease at a reduced rate ϕβ, where ϕ(0,1) can be viewed as a coefficient of the infectivity reduction. The latter stays in line with other models describing the transmission of tuberculosis [27, 28].

    Non-infectious people from the class L(t) (who are the carriers of inactive bacilli) may also develop the active form of the disease when their immune status is changed or altered. Such people progress to the class I(t) at the rate ϵ>0 (see Eqs (2.2b)–(2.2c)). Fully infectious people from the class I(t) are either recruited for treatment at the rate γ>0 and then progress to the class T(t) or they are removed at the disease-induced mortality rate α>0 (see Eqs (2.2c)–(2.2d)).

    Thus, people commencing the treatment become partially infectious and belong to the class T(t). They remain in this class before occurs one of the following events:

    ● they complete treatment and then return to the class L(t) at the rate δ>0, meaning they may still undergo a TB reactivation or relapse towards an active form of the disease;

    ● they abandon treatment before completion, progress to the class I(t) at the rate k>0, and become fully infectious.

    The latter is expressed by Eqs (2.2b)–(2.2d). It is worthwhile to emphasize that here we assume, on the grounds of arguments presented in [6, 7, 8], the non-sterilizing treatment, which is typical for low- and middle-income countries. Finally, Figure 1 exhibits the flow diagram of the TB transmission model (2.2) and Table 1 recaps a detailed description of the model's parameters.

    It should be recalled that TB control in low- and middle-income countries is mainly centered on diagnosing and treating active infections with pharm products bearing low sterilizing effects that are more accessible due to their moderate costs [9, 10].

    Figure 1.  Flow diagram of the TB transmission model (2.2).
    Table 1.  Parameters of the model (2.2).
    Parameter Description Unit
    Λ Recruitment of human individuals person × time1
    μ Natural mortality rate time1
    β TB transmission rate (person × time)1
    ϕ Reduction of the infectiousness by treatment dimensionless
    p Fraction of fast infections dimensionless
    ϵ Rate of slow infection development time1
    δ Rate of the treatment completion time1
    γ Rate of screening/recruitment for treatment time1
    α Disease-induced mortality rate time1
    k Rate of the treatment abandonment time1

     | Show Table
    DownLoad: CSV

    To showcase the well-posedness of the model (2.2), we formulate the following result.

    Proposition 1. For any set of positive initial conditions (2.3), the ODE system (2.2) has a unique nonnegative solution which is ultimately uniformly bounded for all t0.

    Proof. First, we observe that the right-hand sides of the ODE system (2.2) are continuous with respect to the state variables S,L,I, and T. Therefore, this system has a unique solution for any initial condition.

    To prove that all trajectories of the system (2.2) engendered by nonnegative initial conditions (2.3) remain nonnegative for all t0, let us rewrite the Eq (2.2a) in the following form:

    dSdt+h(t)S=Λ,S(0)=S00,whereh(t):=μ+β[I(t)+ϕT(t)].

    Then using the integrating factor, we obtain

    ddt[S(t)et0h(τ)dτ]=Λet0h(τ)dτ.

    This yields

    S(t)et0h(τ)dτS0=t0es0h(τ)dτΛds

    and finally leads to

    S(t)=et0h(τ)dτ(S0+t0es0h(τ)dτΛds)0forallt0.

    A similar rationale can be used to show that L(t)0,I(t)0, and T(t)0 for all t0. Thus, the lower bound for all solutions of the system (2.2) is zero.

    To establish the upper bounds, let us consider the equation for the total population (2.1) which is obtained by summing up the four ODEs of the system (2.2):

    dNdt=ΛαIμN,N(0)=N0=S0+L0+I0+T0.

    From the above equation, we obtain

    dNdtΛμN.

    Thus, if N0Λμ, we have

    N(t)(N0Λμ)eμt+ΛμΛμ.

    Otherwise, if N0>Λμ, then dNdt<0 for some t[0,ˉt] meaning that N(t) is decreasing towards Λμ and its upper bound is N0. Thus, we conclude that

    N(t)max{N0,Λμ}forallt0.

    A direct consequence of Proposition 1 is the existence of the biologically feasible region

    Ω:={(S,L,I,T)R4+: S+L+I+TΛμ} (3.1)

    that contains all possible solutions of the system (2.2) engendered by the initial conditions that satisfy S0+L0+I0+T0Λμ. Therefore, Ω is positively invariant and attracting. The latter implies that Ω contains all possible equilibria of the system (2.2).

    In the present section, we derive the basic reproductive number of the TB transmission model (2.2) and establish the conditions for existence of possible equilibria of the system (2.2) that are nonnegative solutions of the following algebraic system:

    {0=ΛβS(I+ϕT)μS,(3.2a)0=(1p)βS(I+ϕT)+δTϵLμL,(3.2b)0=pβS(I+ϕT)+ϵL+kTγIαIμI,(3.2c)0=γIδTkTμT.(3.2d)

    The disease-free equilibrium (DFE) of the system (2.2) is the solution of (3.2) with L=I=T=0, that is,

    E0:=(Λμ,0,0,0).

    It is easy to see that E0Ω and this equilibrium always exists.

    In epidemiology, one of the core metrics related to the speed of the disease propagation in the human population is the so-called basic reproductive number R0>0. This quantity expresses the expected number of secondary infections produced by one infectious individual in a completely susceptible population during his/her entire period of the infectiousness [29].

    For compartmental epidemiological models, including the proposed model (2.2), the basic reproductive number R0 can be calculated as the largest eigenvalue (or spectral radius) of the next-generation matrix evaluated at the disease-free steady state [30]. Following this approach, let us first define the state sub-vector YR3+ that contains the classes (or compartments) of human hosts carrying the infection, that is,

    Y:=(L,I,T).

    Second, we extract three differential equations corresponding to the components of Y from the ODE system (2.2) and write them in the following form

    dYdt=F(Y)V(Y),

    where F(Y)0 represents the rate of appearance of new infections (or rate of the disease transmission) and V(Y)0 stands for the rate of the disease transition:

    F(Y):=[(1p)(βSI+βϕST)p(βSI+βϕST)0],V(Y):=[(ϵ+μ)LδT(γ+α+μ)I(kT+ϵL)(δ+k+μ)TγI].

    Third, we evaluate the Jacobian matrices of F(Y) and V(Y) at the disease-free equilibrium E0=(Λμ,0,0,0) and obtain

    F:=FY|E0=[0(1p)βΛμ(1p)βϕΛμ0pβΛμpβϕΛμ000],V:=VY|E0=[ϵ+μ0δϵγ+α+μk0γδ+k+μ].

    Then the next-generation matrix FV1 can be written as

    FV1:=βΛμD[(1p)(C+ϕγ)ϵ(1p)(C+ϕγ)A(1p)(Ak+δϵ+ABϕ)p(C+ϕγ)ϵp(C+ϕγ)Ap(Ak+δϵ+ABϕ)000],

    where

    A:=ϵ+μ>0,B:=γ+α+μ>0,C:=δ+k+μ>0 (3.3a)

    denote the elements of V located on its main diagonal, and

    D:=detV=(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ>0. (3.3b)

    Notably, the characteristic polynomial P(λ) of next-generation matrix FV1 admits the following form

    P(λ):=βDΛμ(C+ϕγ)[pA+(1p)ϵ]λ2λ3.

    Given the structure of P(λ), there are two eigenvalues of FV1 which are equal to zero, and the other eigenvalue is exactly the spectral radius of FV1:

    λ=βDΛμ(C+ϕγ)[pA+(1p)ϵ].

    Thus we have

    R0=βΛμ(δ+k+μ+ϕγ)(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ[p(ϵ+μ)+(1p)ϵ]. (3.4)

    The above formula expresses the average number of all secondary infections produced by one infectious individual and, therefore, accounts for the fast and slow development of the disease. Let us recall that the parameter p denotes the fraction of effective contacts leading to the fast TB infections, while (1p) denotes the fraction of effective contacts leading to the slow TB infections. Thus, an alternative form of the formula (3.4) is

    R0=pR0f+(1p)R0s (3.5)

    where

    R0f:=βΛμ(δ+k+μ+ϕγ)(ϵ+μ)(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ=βΛμD(δ+k+μ+ϕγ)(ϵ+μ) (3.6)

    denotes the basic reproductive number of fast tuberculosis, and

    R0s:=βΛμ(δ+k+μ+ϕγ)ϵ(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ=βΛμD(δ+k+μ+ϕγ)ϵ (3.7)

    denotes the basic reproductive number of slow tuberculosis. In the expressions (3.6), (3.7), the positive quantity D is defined by (3.3b).

    The stylized definitions of R0f and R0f given by (3.6) and (3.7) will play a notable role in the process of finding other possible solution(s) to (3.2) as illustrated in the next subsection.

    Our goal is to find out whether the algebraic system (3.2) possesses another feasible solution (S,L,I,T)Ω besides the disease-free equilibrium E0=(Λμ,0,0,0).

    First, from the Eqs (3.2d) and (3.2a) we can express T and S, respectively:

    T=(γδ+k+μ)I, (3.8a)
    S=Λβ(I+ϕT)+μ. (3.8b)

    Then, by plugging (3.8a) into (3.2b) we can also express

    L=[(1p)βSϵ+μ+(1p)βϕγS(ϵ+μ)(δ+k+μ)+γδ(ϵ+μ)(δ+k+μ)]I. (3.8c)

    Now, in Eq (3.2c) we replace T and L by their underlying expressions (3.8a) and (3.8c) to obtain

    pβSI+pβϕγSδ+γ+μI+ϵ[(1p)βSϵ+μ+(1p)βϕγS(ϵ+μ)(δ+k+μ)+γδ(ϵ+μ)(δ+k+μ)]I+γkδ+k+μI(γ+α+μ)I=0.

    The above equation has an obvious solution I=0 which leads us to the disease-free equilibrium E0=(Λμ,0,0,0), and another possible solution is the one satisfying

    [pβ+pβϕγδ+k+μ+(1p)βϵϵ+μ+(1p)βϕγϵ(ϵ+μ)(δ+k+μ)]S+[γδϵ(ϵ+μ)(δ+k+μ)+γkδ+k+μ(γ+α+μ)]=0. (3.9)

    Using the definitions of T and S given by Eqs (3.8a) and (3.8b), we have

    S=Λ(δ+k+μ)β(δ+k+μ+ϕγ)I+μ(δ+k+μ).

    Thus, the expression (3.9) may also be written as

    Pβ(δ+k+μ+ϕγ)I+(δ+k+μ)μ+Q=0, (3.10)

    where

    P:=[pβ+pβϕγδ+k+μ+(1p)βϵϵ+μ+(1p)βϕγϵ(ϵ+μ)(δ+k+μ)]Λ(δ+k+μ), (3.11a)
    Q:=γδϵ(ϵ+μ)(δ+k+μ)+γkδ+k+μ(γ+α+μ). (3.11b)

    Applying the definitions of R0s,R0f,R0, and D (see Eqs (3.3b) and (3.5)–(3.7), respectively), let us try to simplify the expressions for P and Q defined by (3.11). Notably, it follows from (3.11a) that

    P=pβΛ(δ+k+μ)+(1p)βϵΛ(δ+k+μ)ϵ+μ+pβϕγΛ+(1p)βϕγϵΛϵ+μ. (3.12)

    The first and second terms in (3.12) can be rewritten as

    pβΛ(δ+k+μ)μ(ϵ+μ)(δ+k+μ+ϕγ)Dμ(ϵ+μ)(δ+k+μ+ϕγ)D=pμ(δ+k+μ)DR0f(ϵ+μ)(δ+k+μ+ϕγ)

    and

    (1p)βϵΛ(δ+k+μ)ϵ+μμ(δ+k+μ+ϕγ)Dμ(δ+k+μ+ϕγ)D=(1p)μ(δ+k+μ)DR0s(ϵ+μ)(δ+k+μ+ϕγ),

    respectively. Hence, their sum renders

    μ(δ+k+μ)D(ϵ+μ)(δ+k+μ+ϕγ)[pR0f+(1p)R0s]=μ(δ+k+μ)DR0(ϵ+μ)(δ+k+μ+ϕγ). (3.13)

    Similarly, the third and fourth terms in (3.12) can be written as

    pβϕγΛμ(ϵ+μ)(δ+k+μ+ϕγ)Dμ(ϵ+μ)(δ+k+μ+ϕγ)D=pμϕγDR0f(ϵ+μ)(δ+k+μ+ϕγ)

    and

    (1p)βϕγϵΛϵ+μμ(δ+k+μ+ϕγ)Dμ(δ+k+μ+ϕγ)D=(1p)μϕγDR0s(ϵ+μ)(δ+k+μ+ϕγ),

    respectively. Hence, their sum renders

    μϕγD(ϵ+μ)(δ+k+μ+ϕγ)[pR0f+(1p)R0s]=μϕγDR0(ϵ+μ)(δ+k+μ+ϕγ). (3.14)

    Thus, we obtain the final simplified expression for P by summing up (3.13) and (3.14), that is,

    P=μDR0(ϵ+μ)(δ+k+μ+ϕγ)[δ+k+μ+ϕγ]=μDR0ϵ+μ.

    To simplify the expression for Q defined by (3.11b), we rewrite it as follows:

    Q=1(ϵ+μ)(δ+k+μ)[γδϵ+γk(ϵ+μ)(γ+α+μ)(δ+k+μ)(ϵ+μ)]=1(ϵ+μ)(δ+k+μ)[(ϵ+μ)(γδ+γk+γμ+(δ+k+μ)(α+μ)γk)γδϵ]=1(ϵ+μ)(δ+k+μ)[(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+(ϵ+μ)γδγδϵ]=1(ϵ+μ)(δ+k+μ)[(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ]=D(ϵ+μ)(δ+k+μ).

    Now we have

    P=μDR0ϵ+μ,Q=D(ϵ+μ)(δ+k+μ)

    instead of (3.11), and their substitution into (3.10) leads to

    μDR0ϵ+μ1β(δ+k+μ+ϕγ)I+(δ+k+μ)μD(ϵ+μ)(δ+k+μ)=0

    or, equivalently,

    μR0β(δ+k+μ+ϕγ)I+(δ+k+μ)μ=1δ+k+μ

    that can be rewritten as

    μ(δ+k+μ)R0=β(δ+k+μ+ϕγ)I+μ(δ+k+μ).

    Solving this last expression for I, we then obtain

    I=μ(δ+k+μ)(R01)β(δ+k+μ+ϕγ). (3.15)

    Finally, we proceed to formulate the following result regarding the existence of a strictly positive endemic equilibrium E:=(S,L,I,T) of the ODE system (2.2).

    Proposition 2. When R0>1, the ODE system (2.2) has a strictly positive endemic equilibrium E=(S,L,I,T)Ω defined by

    {S=ΛμR0,(3.16a)L=[(1p)Λ(ϵ+μ)R0+γδμβ(ϵ+μ)(δ+k+μ+ϕγ)](R01),(3.16b)I=μ(δ+k+μ)β(δ+k+μ+ϕγ)(R01),(3.16c)T=γμβ(δ+k+μ+ϕγ)(R01).(3.16d)

    Furthermore, EintΩ if α>0, and EΩ if α=0.

    Proof. In the first place, we note that Eq (3.16c) for I has been already derived (see Eq (3.15) above). The coordinates S,L, and T of E can be obtained by plugging I into Eq (3.8) (the underlying computations are omitted here). From the form of Eq (3.16), it is easy to conclude that all coordinates of E are positive whenever R0>1. Moreover, S<Λμ only if R0>1.

    To prove that EΩ, let us define N:=S+L+I+T>0 and show that NΛμ. Notably, S admits the following form:

    S=ΛμΛμR0(R01).

    Using this form for S together with the formulas (3.16b)–(3.16d), we have

    N=Λμ+[ΛμR0+(1p)Λ(ϵ+μ)R0](R01)+[γδμβ(ϵ+μ)(δ+k+μ+ϕγ)+μ(δ+k+μ+γ)β(δ+k+μ+ϕγ)](R01). (3.17)

    Applying the definition of R0 given by (3.4) together with the identity pμ+ϵ=p(ϵ+μ)+(1p)ϵ, the term inside the square brackets in the first row of (3.17) can be rewritten as

    ΛμR0+(1p)Λ(ϵ+μ)R0=pμ+ϵμ(ϵ+μ)R0Λ=Λμ(ϵ+μ)R0[p(ϵ+μ)+(1p)ϵ]=Λ[p(ϵ+μ)+(1p)ϵ](γδμ+(ϵ+μ)[(δ+k+μ)(α+μ)+γμ])μ(ϵ+μ)βΛμ(δ+k+μ+ϕγ)[p(ϵ+μ)+(1p)ϵ]=γδμ+(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]β(ϵ+μ)(δ+k+μ+ϕγ).

    Thus, Eq (3.17) becomes

    N=Λμ+μ(δ+k+μ+γ)(δ+k+μ)(α+μ)γμβ(δ+k+μ+ϕγ)(R01)=Λμα(δ+k+μ)β(δ+k+μ+ϕγ)(R01)Λμ.

    The above relationship clearly indicates that N<Λμ when R0>1 and α>0, meaning that E is an interior equilibrium with respect to Ω. On the other hand, if R0>1 and α=0, then N=Λμ meaning that E is a boundary equilibrium with respect to Ω. Indeed, for α=0 we have that N(t) defined by (2.1) solves the differential equation dNdt=ΛμN.

    In the previous section, it has been shown that the ODE system (2.2) possesses only one equilibrium E0 contained in Ω if R01 and has two equilibria, E0 and E (both contained in Ω) if R0>1.

    In the present section, we analyze the long-term behavior of the TB transmission system (2.2) and establish the stability properties of its equilibria. Notably, the basic reproductive number R0 defined by (3.4) will play the core role in this analysis.

    Let us recall that R0<1 implies that one infectious individual produces, on average, less than one new infection during his/her period of contagiousness. Furthermore, when R0<1, the dynamical system (2.2) has only the disease-free equilibrium E0. Thus, it is expected that (S(t),L(t),I(t),T(t))E0 as t in the "component-by-component" sense, meaning that the disease will eventually die out regardless of its current state. This intuitive rationale is formalized by the following theorem.

    Theorem 1 (Stability properties of the disease-free equilibrium E0). The disease-free equilibrium E0=(Λμ,0,0,0) is globally asymptotically stable when R0<1 and is unstable when R0>1.

    Proof. Let us suppose that R0<1. Under this condition, the disease-free equilibrium E0 is the unique steady state of (2.2) and E0Ω. To establish global stability of E0 we employ the result proposed in [31]. First, we write the vector of states as (S,L,I,T):=(X,Y) where X:=S and Y:=(L,I,T) denote the noninfected and infected classes or compartments, respectively. Using this notation, the disease-free equilibrium becomes E0=(X,0) where X=Λμ. Second, the dynamical system (2.2) should be put into the form

    {dXdt=F(X,Y),(4.1a)dYdt=G(X,Y),G(X,0)=0.(4.1b)

    The latter is accomplished by defining

    F(X,Y):=ΛβS(I+ϕT)μS, (4.2a)
    G(X,Y):=[(1p)βS(I+ϕT)+δT(ϵ+μ)LpβS(I+ϕT)+ϵL+kT(γ+α+μ)IγI(δ+k+μ)T]. (4.2b)

    According to [31], the following conditions must be met to guarantee both local and global stability of E0=(X,0):

    (H1) X is globally asymptotically stable equilibrium of the system dXdt=F(X,0).

    (H2) If Ω is the set where the model (4.1) makes biological sense, then for all (X,Y)Ω the function G(X,Y) in (4.1b) admits the following form:

    G(X,Y)=AYˆG(X,Y),withˆG(X,Y)0(X,Y)Ω

    where A:=GY|E0 is a Metzler matrix (all its off-diagonal elements are nonnegative).

    Third, we verify the conditions (H1)–(H2) stated above bearing in mind that ΩR4+ is defined by (3.1). Notably, for F(X,Y) defined by (4.2a), we have that dXdt=F(X,0) reduces to a single ODE

    dXdt=ΛμX.

    This equation possesses a unique equilibrium X=Λμ, which is globally asymptotically stable for all X0. Thus, condition (H1) holds. Regarding the condition (H2), we observe that (4.2b) can be written as G(X,Y)=AYˆG(X,Y) with A and ˆG(X,Y) given by

    A=GY|E0=((ϵ+μ)(1p)βΛμ(1p)βϕΛμ+δϵpβΛμ(γ+α+μ)pβϕΛμ+k0γ(δ+k+μ)) (4.3)

    and

    ˆG(X,Y)=((1p)β(I+ϕT)(ΛμS)pβ(I+ϕT)(ΛμS)0), (4.4)

    respectively. It is immediate to check via (4.3) that Aij0 when ij and i,j=1,2,3. Therefore, A is a Metzler matrix. From (4.4) it also follows that ˆG(X,Y)0 for all (X,Y)Ω since it holds that 0SΛμ. Thus, both conditions (H1)–(H2) are verified, and this completes the proof that E0 is a globally asymptotically stable equilibrium of the system (2.2) whenever R0<1.

    Now, let us suppose that R0>1. To prove that E0 is unstable under this condition, it is sufficient to show that the Jacobian matrix J(E0) of the system (2.2) evaluated at E0 has at least one eigenvalue with positive real part whenever R0>1. Using the positive quantities A,B, and C introduced by the relationships (3.3a) in Section 3, it is easy to deduce that

    J(E0)=(μ0βΛμβϕΛμ0A(1p)βΛμ(1p)βϕΛμ+δ0ϵpβΛμBpβϕΛμ+k00γC).

    Let us also recall that

    detJ(E0)=4i=1λi,

    where λi,i=1,2,3,4 denote four eigenvalues of J(E0). Therefore, it suffices to show that detJ(E0)<0 whenever R0>1. Indeed,

    detJ(E0)=μ(A(1p)βΛμ(1p)βϕΛμ+δϵpβΛμBpβϕΛμ+k0γC)=μAdet(pβΛμBpβϕΛμ+kγC)+μϵdet((1p)βΛμ(1p)βϕΛμ+δγC)=μA[BCCpβΛμγpβϕΛμkγ]+μϵ[C(1p)βΛμγ(1p)βϕΛμγδ]=μ[(ABCϵγδkγA)A(CpβΛμ+γpβϕΛμ)ϵ(C(1p)βΛμ+γ(1p)βϕΛμ)].

    In the above expression, we observe that

    ABCϵγδkγA=detV=D

    in virtue of the relationship (3.3b). Furthermore, R0 admits the form

    R0=βDΛμ(C+γϕ)[pA+(1p)ϵ].

    Thus, we have

    detJ(E0)=μ(DβΛμ(C+γϕ)[pA+(1p)ϵ])=μD(1R0).

    Therefore, detJ(E0)<0 whenever R0>1 and E0 is unstable if R0>1. This completes the proof of Theorem 1.

    It is worthwhile to note that E0 cannot be a repeller when R0>1 since J(E0) possesses at least one strictly negative eigenvalue (λ1=μ<0). Thus, E0 is a saddle point. In fact, when R0>1 the solution of the system (2.2) engendered by the initial conditions (S0,0,0,0)E0 with S0Λμ converges to E0.

    Let us recall that R0>1 implies that one infectious individual produces, on average, more than one new infection during his/her period of contagiousness. It was also shown in Section 3 that, when R0>1, the dynamical system (2.2) has two equilibria: the disease-free equilibrium E0 and the endemic equilibrium EΩ whose coordinates are strictly positive and defined by (3.16). Moreover, Theorem 4.1 has established that the disease-free equilibrium E0 is unstable when R0>1 meaning that E0 is hardly reachable when R0>1. Thus it is expected that (S(t),L(t),I(t),T(t))E as t in the "component-by-component" sense, the endemic equilibrium E can be eventually reached, and the disease may persist regardless of its current state. This intuitive rationale is formalized by the following theorem.

    Theorem 2 (Stability properties of the endemic equilibrium E). When R0>1, the endemic equilibrium E=(S,L,I,T) is globally asymptotically stable in the open set ΩΩ where

    Ω:={(S,L,I,T)Ω: L+I+T>0}.

    Proof. As stated by Proposition 2, the endemic equilibrium E=(S,L,I,T) defined by (3.16) exists whenever R0>1 and EΩ. To prove that E is globally stable in Ω, we will use the so-called Lyapunov-LaSalle theorem (see, e.g., Theorem 6.2 in [32]). The first step is to construct a Lyapunov function for the ODE system (2.2). Let us recall that a continuously differentiable scalar function V:R4+R is a Lyapunov function of model (2.2) if it has the following properties [33]:

    (i) V(E)=0;

    (ii) V(S,L,I,T) is radially unbounded in R4+;

    (iii) ddtV(S,L,I,T)0 for all (S,L,I,T)R4+ and t0.

    A good candidate for V(S,L,I,T) is the separable scalar function proposed by B. Goh [33, p10] which is radially unbounded and has been used by many scholar in the context of TB transmission models (see, e.g., [20, 21, 27, 34] and references therein). Therefore, let us consider the following form of V:

    V(S,L,I,T)=[SSSln(SS)]+B1[LLLln(LL)]+B2[IIIln(II)]+B3[TTTln(TT)], (4.5)

    where B1, B2, and B3 are positive constants to be determined. Notably, function V defined by (4.5) fulfills items (i) and (ii) mentioned above, while item (iii) requires further considerations. Namely, we should find the proper positive values for B1, B2, and B3 so that the orbital derivative of V (i.e., the time derivative of V along all solutions of the system (2.2)) be nonpositive. For further analysis, it will be convenient to consider an alternative form of (3.2) which is satisfied by the coordinates (S,L,I,T) of E:

    Λ=βS(I+ϕT)+μS, (4.6a)
    (ϵ+μ)L=(1p)βS(I+ϕT)+δT, (4.6b)
    (γ+α+μ)I=pβS(I+ϕT)+ϵL+kT, (4.6c)
    (δ+k+μ)T=γI. (4.6d)

    These relationships will play an important role in the sequel. Using the chain rule together with (4.6), the orbital derivative of V can be written as

    dVdt=(1SS)dSdt+B1(1LL)dLdt+B2(1II)dIdt+B3(1TT)dTdt, (4.7)

    where the first term is

    (1SS)dSdt=(1SS)[ΛβS(I+ϕT)μS]invirtueof(4.6a)=(1SS)[βS(I+ϕT)+μSβS(I+ϕT)μS]=μ(SS)2S+βS(I+ϕT)(1SS)βS(I+ϕT)+βS(I+ϕT).

    The second and the third terms in the right-hand side of (4.7) can be written, respectively, as

    B1(1LL)dLdt=B1(1LL)[(1p)βS(I+ϕT)+δT(ϵ+μ)L]=B1(1LL)[(1p)βS(I+ϕT)+δT]B1(ϵ+μ)L+B1(ϵ+μ)L=B1(1LL)[(1p)βS(I+ϕT)+δT]B1(ϵ+μ)L+B1[(1p)βS(I+ϕT)+δT]invirtueof(4.6b)

    and

    B2(1II)dIdt=B2(1II)[pβS(I+ϕT)+ϵL+kT(γ+α+μ)I]=B2(1II)[pβS(I+ϕT)+ϵL+kT]B2(γ+α+μ)I+B2(γ+α+μ)I=B2(1II)[pβS(I+ϕT)+ϵL+kT]B2(γ+α+μ)I+B2[pβS(I+ϕT)+ϵL+kT]invirtueof(4.6c),

    while the last term of (4.7) gives

    B3(1TT)dTdt=B3(1TT)[γI(δ+k+μ)T]=B3(1TT)γIB3(δ+k+μ)(TT)=B3(1TT)γIB3(δ+k+μ)T+B3γIinvirtueof(4.6d).

    Using the expressions from the four previous formulas and making some laborious rearrangements, the orbital derivative of V can be written as

    dVdt=μ(SS)2S+βS(I+ϕT)(1SS)+βS(I+ϕT)[(1p)B1+pB21]+L[B1(ϵ+μ)+B2ϵ]+I[βSB2(γ+α+μ)+B3γ]+T[ϕβS+B1δ+B2kB3(δ+k+μ)]B1(1p)βLSILB1(1p)ϕβLSTLB1δLTLB2pβISB2pϕβISTIB2ϵILIB2kITIB3γTIT+B1(1p)βS(I+ϕT)+B2pβS(I+ϕT)+B1δT+B2ϵL+B2kT+B3γI.

    Now the positive constants B1, B2, and B3 should be chosen in a way that the coefficients of S(I+ϕT), L, I, and T in the above expression become equal to zero, that is, the following four equations must be satisfied:

    {(1p)B1+pB21=0(γ+α+μ)B2+γB3+βS=0δB1+kB2(δ+k+μ)B3+ϕβS=0(ϵ+μ)B1+ϵB2=0

    This is a tedious task, so we present here the final solution of (4.8), while the meticulous details are moved to Appendix A:

    B1=ϵ(1p)ϵ+p(ϵ+μ)>0, (4.9a)
    B2=ϵ+μ(1p)ϵ+p(ϵ+μ)>0, (4.9b)
    B3=δB1+[k+ϕ(γ+α+μ)]B2δ+k+μ+ϕγ>0. (4.9c)

    With B1, B2 and B3 defined by (4.9), the orbital derivative of V becomes

    dVdt=μ(SS)2S+βS(I+ϕT)(1SS)B1(1p)βLSILB1(1p)ϕβLSTLB1δLTLB2pβISB2pϕβISTIB2ϵILIB2kITIB3γTIT+B1(1p)βS(I+ϕT)+B2pβS(I+ϕT)+B1δT+B2ϵL+B2kT+B3γI.

    For convenience, we introduce new variables

    x:=SS,y:=LL,z:=II,u:=TT

    to eliminate S,L,I and T in the expression for dVdt. Here, we observe that for B1 and B2 satisfying the Eq (4.8a) it holds that

    βS(I+ϕT)(1SS)=[(1p)B1+pB2]βS(I+ϕT)(11x).

    Keeping in mind this relationship, the orbital derivative of V can be written as

    dVdt=μS(x1)2x+B1(1p)βSI(21xxzy)+B1(1p)ϕβST(21xxuz)+B2pβSI(21xx)+B2pϕβST(21xxuz)+B1δT(1uy)+B2kT(1uz)+B2ϵL(1yz)+B3γI(1zu). (4.10)

    Following the idea proposed in [27], we multiply the Eq (4.6b) by B1 and the Eq (4.8d) by L in order to obtain

    (ϵ+μ)LB1=B1(1p)βS(I+ϕT)+B1δT,(ϵ+μ)LB1=B2ϵL.

    Hence, it follows that

    B2ϵLB1(1p)βS(I+ϕT)B1δT=0. (4.11)

    Similarly, we multiply the Eq (4.6d) by B3 and the Eq (4.8c) by T and obtain

    (δ+k+μ)TB3=B3γI,(δ+k+μ)TB3=B1δT+B2kT+ϕβST.

    Then we have

    B3γIB1δTB2kTϕβST=0. (4.12)

    Let F1(Z) and F2(Z),Z:=(x,y,z,u) be two scalar functions which will be defined later. Then it is also fulfilled that

    B2ϵLF1(Z)B1(1p)βS(I+ϕT)F1(Z)B1δTF1(Z)=0B3γIF2(Z)B1δTF2(Z)B2kTF2(Z)ϕβSTF2(Z)=0

    in virtue of (4.11) and (4.12). By summing the above expressions (both equal to zero) to the right-hand side of formula (4.10) and rearranging some terms, the orbital derivative of V becomes

    dVdt=μS(x1)2x+B1(1p)βSI(21xxzyF1(Z))+B1(1p)ϕβST(21xxuyF1(Z)F2(Z))+B2pβSI(21xx)+B2pϕβST(21xxuzF2(Z))+B1δT(1uyF1(Z)F2(Z))+B2kT(1uzF2(Z))+B2ϵL(1yz+F1(Z))+B3γI(1zu+F2(Z)).

    To make vanish the last two summands in the above formula, we choose the functions F1(Z) and F2(Z) in the following way:

    F1(Z):=yz1,F2(Z):=zu1.

    Using this selection of F1(Z) and F2(Z), the orbital derivative of V is now written as

    dVdt=μS(x1)2x+B1(1p)βSI(31xxzyyz)+B1(1p)ϕβST(41xxuyyzzu)+B2pβSI(21xx)+B2pϕβST(31xxuzzu)+B1δT(3uyyzzu)+B2kT(2uzzu). (4.14)

    Finally, to demonstrate that dVdt0, we observe that the first term in the right-hand side of (4.14) is strictly negative whenever x1 or, equivalently, whenever SS. However, this term vanishes when S=S. Further, we apply the so-called "arithmetic mean – geometric mean inequality" (see, e.g., [35] or similar textbooks) to all other terms on the right-hand side of (4.14) and obtain that they are nonpositive for any positive (x,y,z,u) and vanish only if

    x=1andy=z=umeaningthatS=SandLL=II=TT.

    Thus V=V(S,L,I,T) defined by (4.5) with positive constants B1,B2 and B3 satisfying (4.9) is a Lyapunov function for the system (2.2) and we also have

    dVdt<0forall(S,L,I,T)ΩΩ0,

    where

    Ω0:={(S,L,I,T)Ω: dVdt=0}={(S,L,I,T)Ω: S=SandLL=II=TT}.

    Notably, the largest invariant subset of Ω0 is the singleton E (endemic equilibrium). Then in virtue of the Lyapunov-LaSalle theorem [32, Theorem 6.2, p. 138], every solution of (2.2) engendered by an initial condition (S0,L0,I0,T0)Ω converges to E when t. In other words, E is globally asymptotically stable in Ω. This completes the proof of Theorem 2.

    Summarizing the results presented so far, we conclude that the number of equilibria of the system (2.2) located in Ω, together with their stability, is determined by the value of the basic reproductive number R0. It is also clear that the dynamical system (2.2) undergoes a forward (or transcritical) bifurcation at R0=1 which is depicted in Figure 2. In the bifurcation diagram, the values of R0 are located on the horizontal axis, and the vertical axis corresponds to the equilibrium size of population groups contributing to the disease spread (that is, L+I+T). In Figure 2, an asymptotically stable equilibrium (E0 if R0<1 or E if R0>1) is depicted by a red solid line, while a black dashed line displays the unstable equilibrium E0 only if R0>1.

    Figure 2.  Bifurcation diagram for the model (2.2).

    Thus, when R0 changes its value due to perturbation of some parameter(s) included in its expression (3.4), either from less than unity to greater than unity or vice versa, it alters the long-term behavior of the system (2.2).

    In the preceding sections, it has been shown that the four-dimensional TB transmission model (2.2) is biologically meaningful and well-posed. Furthermore, this model exhibits rather explicit stability properties tightly related to the basic reproductive number R0 that are highly desirable in epidemiological modeling.

    Let us briefly illustrate that the proposed model (2.2) exhibits the behavior predicted by Theorems 4.1 and 4.2 given in Section 4. Having assigned plausible values to all constant parameters of the model (2.2) (see Table 2), we proceed to solve numerically the ODE system (2.2) using Mathematica 12 software tool under two illustrative scenarios:

    Table 2.  Numerical values of parameters of the model (2.2); time is measured in years.
    Parameter Value Range References/Comments
    Λ 32000 assumed
    μ 177 assumed
    β 1.65×107 [0.01Λ/μ,1Λ/μ] fitted
    [2ex] ϕ 0.25 (0,1) [26, 37]
    p 0.05 [0.025,0.3] [22, 24, 38]
    ϵ 0.05 [0.004,0.2] [20, 36]
    δ 1.5 [1.125,1.5] [36, 37]
    γ 2 [0.3,2.5] [19, 20, 36]
    α 0.03 [0.0227,0.3] [24, 36]
    k varied [0,0.5] [19, 20]

     | Show Table
    DownLoad: CSV

    Scenario 1: TB transmission without treatment abandonment (k=0);

    Scenario 2: TB transmission with treatment abandonment (k=0.3>0).

    We first recall that tuberculosis is a social disease that is easily spread under crowded conditions of big cities [1]. Therefore, we take as an example a city with an average population of 2.5 million people and scale the parameter Λ accordingly. The average life expectancy varies between 66 and 88 depending on the country, and we assume it is equal to 77 years. Furthermore, in 2019, the TB incidence per year varied between 0 and 654 cases per 100000 inhabitants in different countries§, and we fit the value of β to match the TB incidence of approximately 250 cases per 100000 inhabitants per year. Numerical values of other parameters and their underlying ranges are borrowed from the existing literature.

    For more information on life expectancy, please refer to the WORLDOMETER website (https://www.worldometers.info/demographics/life-expectancy/)

    §More information is available at The World Bank Data (https://data.worldbank.org/indicator/SH.TBS.INCD)

    For both scenarios, we assign the same set of initial conditions that are relatively close to the endemic equilibrium E. The coordinates of E are calculated using four formulas of (3.16):

    E=(S,L,I,T)=(2.35×106,100585,2981,3288).

    The initial conditions should fulfill the relationship N(0)=S(0)+L(0)+I(0)+T(0)=2.5×106, and we assume that

    S(0)=N(0)L(0)I(0)T(0),L(0)=1.15L,I(0)=1.15I,T(0)=1.15T. (5.1)

    We are interested in the time evolution of two infectious groups: I-class (fully capable of transmitting the disease) and T-class (partially infectious). Their profiles are presented in Figure 3 for short-term (left column) and long-term evolution (right column).

    Figure 3.  System profiles of the infectious classes I (upper charts) and T (lower charts) for short-term evolution (left column) and long-term evolution (right column); the curves corresponding to Scenario 1 and Scenario 2 are depicted by dashed and solid lines, respectively, while the dotted horizontal lines mark the underlying coordinates of the endemic equilibrium.

    Notably, Figure 3 reveals different short- and long-term tendencies of the disease propagation for Scenario 1 (dashed-line curves) and Scenario 2 (solid-line curves), and this has a straightforward explanation from the standpoint of Theorems 1 and 2. Namely, since

    R0|k=0=0.928997<1andR0|k=0.3=1.04839>1, (5.2)

    the trajectories of the system (2.2) converge either to the disease-free equilibrium E0 (under Scenario 1) or to the endemic equilibrium E (under Scenario 2). Thus, theoretical findings presented in Sections 3 and 4 are confirmed by numerical simulations of the proposed TB transmission model.

    Let us now recall the primary reason why this model has been proposed. Namely, we intended to include the group of patients who abandon treatment before its completion, without assigning them to an additional class and, thus, retaining only the four original compartments of the model (S,L,I and T). Therefore, we proceed now to analyze the effect of treatment abandonment on disease transmission.

    The model should reflect that TB-positive patients who abandon treatment before completion contribute to the disease spread by passing from "partially infectious" to "fully infectious". Let us verify if the proposed model (2.2) fulfills this expectation by analyzing the partial derivative of R0 with respect to k, the parameter expressing the rate of treatment abandonment:

    R0k=βΛμγ((ϵ+μ)[μϕ(α+μ)]+δμ)((ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ)2[p(ϵ+μ)+(1p)ϵ].

    Thus R0 is an increasing function of k whenever

    (ϵ+μ)[μϕ(α+μ)]+δμ>0, (5.3)

    that is, for all α such that

    0α<α:=μϕ(ϵ+μ)[δ+(1ϕ)(ϵ+μ)]. (5.4)

    Notably, the relationship (5.3) holds trivially if α=0, i.e. if there is no disease-induced mortality. Furthermore, for any positive value of α below the threshold α (defined by formula (5.4) above), an increase in the rate of treatment abandonment k would increase the value of R0. In other words, by increasing k, a greater average number of secondary TB infections could be expected from one person carrying active bacilli.

    However, if α>α, the basic reproductive number R0 is a decreasing function of the treatment abandonment rate k. In this case, a smaller average number of secondary TB infections could be expected from one actively infected person if k is increased. The rationale behind this statement is rather simple and intuitive. When the disease-induced mortality is high (α>α), more people are removed from the I-class per unit time, meaning that they stop spreading the infection. As k increases, more people pass from the "partially infectious" T-class to the "fully infectious" I-class, from which they are fastly removed (because α is high) instead of remaining in the system and bearing a reduced capacity of infecting the others. As a consequence, when k increases, one infectious individual produces, on average, a smaller number of secondary infections, meaning that R0 is a decreasing function of k when α>α. Furthermore, it is easy to check that R0 is a decreasing function of α:

    R0α=βΛμ(ϵ+μ)(δ+k+μ)((ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ)2[p(ϵ+μ)+(1p)ϵ]<0.

    Let us now examine the behavior of R0 as a function of k (treatment abandonment rate) and α (disease-induced mortality rate), which is denoted by R0:=R0(k,α) and displayed by a yellow-colored surface in Figure 4. In this figure, the green-colored horizontal plane indicates the threshold surface R0=1. The intersection between R0(k,α) and R0=1 is marked by a red-colored curve.

    Figure 4.  Basic reproductive number R0 as a function of k (treatment abandonment rate) and α (disease-induced mortality rate).

    When both arguments of the function R0(k,α) take values corresponding to Scenario 1, that is, k=0 and α=0.03, the respective point R0(0,0.03) lies below the threshold plane R0=1. On the other hand, the point R0(0.3,0.03) corresponding to Scenario 2 is located above the threshold plane R0=1. It is also displayed in Figure 4 that if k=0.3 but α is enhanced to α=0.15, the respective point R0(0.3,0.15) of the yellow-colored surface R0(k,α) lies below the green-colored threshold plane R0=1.

    Thus, from a purely mathematical standpoint, the current value of R0 can be driven below 1 either by reducing the treatment abandonment rate k or by augmenting the disease-induced mortality rate α. Naturally, the former seems a lot more reasonable and compelling than the latter, meaning that even a small reduction in k (ceteris paribus) can certainly abate the disease propagation. Two charts displayed in Figure 5 depict these tendencies for variation of each parameter within its range, while other parameters retain their values determined in Table 2. Namely, the left chart shows the change in the value of R0 as a function Rk0(k) that depends only on k[0,0.5]. Similarly, the right chart shows the change in the value of R0 as a function Rα0(α) that depends only on α[0,0.3]. The black points on both charts of Figure 5 mark the critical values kc=0.1771 and αc=0.0493 such that Rk0(kc)=1 and Rα0(αc)=1, respectively.

    Figure 5.  Basic reproductive number represented by one-parameter functions: Rk0(k) depends only on the treatment abandonment rate k[0,0.5] while α=0.03 (left chart) and Rα0(α) depends only on the disease-induced mortality rate α[0,0.3] while k=0.3 (right chart).

    To conclude this section, let us assess the negative effect of the treatment abandonment in terms of additional active TB infections it may cause and additional deaths it may induce. For that purpose, let us introduce two auxiliary variables:

    C(t):=t0[pβ(I(τ)+ϕT(τ))S(τ)+ϵL(τ)+kT(τ)]dτandM(t):=t0αI(τ)dτ.

    The first one, C(t), denotes the cumulative incidence and expresses the overall number of active TB infections that appear during the period [0,t]. The second one, M(t), denotes the cumulative disease-induced mortality and expresses the overall number of TB-infected people who died of the disease during the period [0,t]. Notably, in the above expressions, the variables S,L,I and T are solutions of the system (2.2) engendered by the initial conditions (5.1) when other parameters take values from Table 2. Hence C(t) and M(t) can be viewed as solutions of the following differential equations with underlying initial conditions

    dCdt=pβ(I+ϕT)S+ϵL+kT,C(0)=0, (5.5a)
    dMdt=αI,M(0)=0. (5.5b)

    Thus, we can compose a six-dimensional ODE system by complementing the original model (2.2) with two auxiliary Eqs (5.5) and solve it numerically using the Mathematica software package for two scenarios established earlier. Figure 6 exhibits the cumulative incidence C(t) (left chart) and cumulative mortality M(t) (right chart) under Scenario 1 (dashed-line curves) and Scenario 2 (solid-line curves) when t[0,3].

    Figure 6.  Cumulative incidence C(t) (left chart) and cumulative mortality M(t) (right chart) obtained by numerical solution of the six-dimensional system (2.2), (5.5); the curves corresponding to Scenario 1 and Scenario 2 are depicted by dashed and solid lines, respectively.

    Our numerical simulations also allow to estimate, through the model, how many new infections and fatalities may occur by the end of the observation period (3 years) under both scenarios. In effect, we have that

    C(3)|k=0=17441,C(3)|k=0.3=21016(cumulativenewTBinfections)M(3)|k=0=265,M(3)|k=0.3=309(cumulativeTBinducedfatalities)

    Thus, if the treatment abandonment rate is reduced from k=0.3 to k=0 and then for three years no patient abandons treatment, it may help to avoid about 3725 active TB infections together with 44 TB-induced fatalities in a population of 2.5 million people.

    In the present paper, we have proposed and justified a synthesized version of the tuberculosis transmission model that accounts for treatment abandonment. A distinctive feature of this model is that it contains only four standard state variables or compartments expressing the classes of susceptible, latently infected, actively infected, and treated individuals, while other models accounting for treatment abandonment contain more state variables [19, 20, 21, 22, 23].

    It was also shown that the proposed model is biologically meaningful and well-posed from a mathematical standpoint. We have also rigorously proved that the proposed model exhibits the properties of global stability that are highly desirable in epidemiological modeling, and this constitutes another characteristic attribute of our model. The qualitative analysis of the system behavior with treatment desertion is helpful for a better understanding of the endemic persistence of tuberculosis. It also explains why this infectious disease is difficult to exterminate.

    Furthermore, the proposed model enables us to visualize that the treatment abandonment enhances the incidence of the disease and disease-induced mortality. This is an important feature that may motivate the patients with active TB not to abandon their ongoing treatment and thus to avoid new infections and fatalities. On the other hand, the model also revealed that a reduction of the treatment abandonment rate has a positive effect on the disease incidence and results in avoiding disease-related fatalities.

    Once our lower-dimensional model with treatment desertion is rigorously justified from the theoretical standpoint, this model can be further used for fitting the realistic data of active TB infections detected, patients being treated, and treatment abandonment cases. Since tuberculosis is a social disease, its spread depends on social strata that may feature lower/higher transmission and treatment abandonment rates. In this context, adding social heterogeneity through the metapopulation or network-based modeling approaches [39, 40] in combination with parameter estimations [41] brings forward a germane outlook for our future research.

    This research was funded by the National Fund for Science, Technology, and Innovation (Autonomous Heritage Fund Francisco José de Caldas) by way of the Research Program No. 1106-852-69523 (Principal Investigator: Hector J. Martinez-Romero), Contract: CT FP 80740-439-2020 (Colombian Ministry of Science, Technology, and Innovation-Minciencias), Grant ID: CI-71243 (Universidad del Valle, Colombia). Hanner E. Bastidas-Santacruz acknowledges support from Universidad del Valle through Project CI-71309 for institutional support of Master course students.

    The authors declare that there is no conflict of interest.

    For convenience, the algebraic System (4.8) is replicated here

    {(1p)B1+pB21=0(γ+α+μ)B2+γB3+βS=0δB1+kB2(δ+k+μ)B3+ϕβS=0(ϵ+μ)B1+ϵB2=0

    and we immediately observe that system (A-1) is over-determined for it has four equations in only three unknowns B1,B2, and B3. Nonetheless, we can prove that the positive constants B1,B2 and B3 defined by (4.9) are solutions of all four equations of (A-1).

    First, from Eq (A-1d) we obtain

    B1=ϵϵ+μB2,

    and plugging this expression into Eq (A-1a) we get

    (1p)ϵϵ+μB2+pB2=1B2[(1p)ϵ+p(ϵ+μ)ϵ+μ]=1,

    so that

    B1=ϵ(1p)ϵ+p(ϵ+μ)>0,B2=ϵ+μ(1p)ϵ+p(ϵ+μ)>0

    coincide with (4.9a) and (4.9b).

    Further, Eq (A-1b) multiplied by ϕ is added to Eq (A-1c) and yields

    δB1+[k+ϕ(γ+α+μ)]B2(δ+k+μ+ϕγ)B3=0B3=δB1+[k+ϕ(γ+α+μ)]B2δ+k+μ+ϕγ>0

    This formula agrees with (4.9c).

    Let us now verify that B1,B2, and B3 defined by (4.9) effectively satisfy all four equations of the System (A-1) (which are identical to (4.8)). Verification of Eqs (A-1a) and (A-1d) seems rather trivial and we omit it here. To verify (A-1b) and (A-1c), we recall the definition of S,R0 and D provided by the formulas (3.16a), (3.4) and (3.3b), respectively.

    S=ΛμR0,R0=βΛ(δ+k+μ+ϕγ)μD[p(ϵ+μ)+(1p)ϵ],
    D=(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]+γδμ.

    From the above relationships, we can also deduce an alternative form of B2 that will be used in the sequel:

    B2=βΛ(ϵ+μ)(δ+k+μ+ϕγ)μDR0. (A-2)

    We begin by proving that Eq (A-1b) is satisfied:

    (γ+α+μ)B2+γB3+βS=(γ+α+μ)B2+γδϵϵ+μB2+[k+ϕ(γ+α+μ)]γB2δ+k+μ+ϕγ+βS
    =B2δ+k+μ+ϕγ[(γ+α+μ)(δ+k+μ+ϕγ)+γδϵϵ+μ+γk+ϕγ(γ+α+μ)]+βS
    =B2δ+k+μ+ϕγ[ϕγ(γ+α+μ)(γ+α+μ)(δ+k+μ)+γδϵϵ+μ+γk+ϕγ(γ+α+μ)]+βS
    =B2δ+k+μ+ϕγ[γδγkγμ(α+μ)(δ+k+μ)+γδϵϵ+μ+γk]+βS=B2δ+k+μ+ϕγ[γδϵγδμ(ϵ+μ)[(α+μ)(δ+k+μ)+γμ]+γδϵϵ+μ]+βS
    =B2D(ϵ+μ)(δ+k+μ+ϕγ)+βSreplacingB2by(A2)=βΛ(ϵ+μ)(δ+k+μ+ϕγ)DμDR0(ϵ+μ)(δ+k+μ+ϕγ)+βS=βΛμR0+βS0.

    The latter implies that Eq (A-1b) is fulfilled by B1,B2 and B3 defined by (4.9). To complete our verification, we check the Eq (A-1c):

    δB1+kB2(δ+k+μ)B3+ϕβS=δϵB2ϵ+μ+kB2(δ+k+μ)δϵB2ϵ+μ+[k+ϕ(γ+α+μ)]B2δ+k+μ+ϕγ+ϕβS
    =B2δ+k+μ+ϕγ[δϵ(δ+k+μ)ϵ+μ+ϕγδϵϵ+μ+k(δ+k+μ)+ϕγkδϵ(δ+k+μ)ϵ+μk(δ+k+μ)ϕ(δ+k+μ)(γ+α+μ)]+ϕβS
    =ϕB2δ+k+μ+ϕγ[γδϵϵ+μ+γk(δ+k+μ)(α+μ)γδγkγμ]+ϕβS=ϕB2δ+k+μ+ϕγ[γδϵ(ϵ+μ)[(δ+k+μ)(α+μ)+γμ]γδϵγδμϵ+μ]+ϕβS
    =ϕB2D(ϵ+μ)(δ+k+μ+ϕγ)+ϕβSreplacingB2by(A2)=ϕβΛ(ϵ+μ)(δ+k+μ+ϕγ)DμDR0(ϵ+μ)(δ+k+μ+ϕγ)+ϕβS=ϕβΛμR0+ϕβS0.

    Thus, we have proven that positive quantities B1,B2 and B3 defined by (4.9) are solutions of all four Eqs (A-1).



    [1] A. Prasad, A. Ross, P. Rosenberg, C. Dye, A world of cities and the end of TB, Trans. R. Soc. Tropical Med. Hyg., 110 (2016), 151–152. https://doi.org/10.1093/trstmh/trw004 doi: 10.1093/trstmh/trw004
    [2] M. Saunders, C. Evans, Fighting poverty to prevent tuberculosis, Lancet. Infect. Dis., 16 (4), 395–396. https://doi.org/10.1016/S1473-3099(15)00434-X
    [3] World Health Organization, Global Tuberculosis Report 2018, 2018. Available from: https://www.who.int/publications/i/item/9789241565646.
    [4] N. Meier, M. Jacobsen, T. Ottenhoff, N. Ritz, A systematic review on novel Mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis, Front. Immunol., 9 (2018), 2476. https://doi.org/10.3389/fimmu.2018.02476 doi: 10.3389/fimmu.2018.02476
    [5] L. Connolly, P. Edelstein, L. Ramakrishnan, Why is long-term therapy required to cure tuberculosis?, PLoS Med., 4 (2007), e120. https://doi.org/10.1371/journal.pmed.0040120 doi: 10.1371/journal.pmed.0040120
    [6] C. Beltran, T. Heunis, J. Gallant, R. Venter, N. Du Plessis, A. Loxton, et al., Investigating non-sterilizing cure in TB patients at the end of successful anti-TB therapy, Front. Cell. Infect. Microbiol., 10 (2020), 443. https://doi.org/10.3389/fcimb.2020.00443 doi: 10.3389/fcimb.2020.00443
    [7] G. Walzl, K. Ronacher, W. Hanekom, T. Scriba, A. Zumla, Immunological biomarkers of tuberculosis, Nat. Rev. Immunol., 11 (2011), 343–354. https://doi.org/10.1038/nri2960 doi: 10.1038/nri2960
    [8] R. Wallis, S. Vinhas, J. Johnson, F. Ribeiro, M. Palaci, R. Peres, et al., Whole blood bactericidal activity during treatment of pulmonary tuberculosis, J. Infect. Dis., 187 (2003), 270–278. https://doi.org/10.1086/346053 doi: 10.1086/346053
    [9] P. MacPherson, R. Houben, J. Glynn, E. Corbett, K. Kranzer, Pre-treatment loss to follow-up in tuberculosis patients in low-and lower-middle-income countries and high-burden countries: A systematic review and meta-analysis, Bull. World Health Organ., 92 (2013), 126–138. https://doi.org/10.2471/BLT.13.124800 doi: 10.2471/BLT.13.124800
    [10] T. Tanimura, E. Jaramillo, D. Weil, M. Raviglione, K. Lönnroth, Financial burden for tuberculosis patients in low-and middle-income countries: A systematic review, Eur. Respir. J., 43 (2014), 1763–1775. https://doi.org/10.1183/09031936.00193413 doi: 10.1183/09031936.00193413
    [11] G. Bezerra, T. Araujo, T. Silva, J. Teixeira, T. Magalhães, M. Duarte, Prevalence and associated factors of tuberculosis treatment abandonment, Revista da Escola de Enfermagem da USP, 55 (2021), e03767. https://doi.org/10.1590/S1980-220X2020039203767 doi: 10.1590/S1980-220X2020039203767
    [12] N. Gomes, M. Bastos, R. Marins, A. Barbosa, L. Soares, A. de Abreu, et al., Differences between risk factors associated with tuberculosis treatment abandonment and mortality, Pulm. Med., 2015 (2015). https://doi.org/10.1155/2015/546106 doi: 10.1155/2015/546106
    [13] J. Trauer, Mathematical Modelling for Programmatic Responses to Tuberculosis in the Asia-Pacific, Ph.D thesis, The University of Melbourne, 2016.
    [14] C. Castillo-Chavez, Z. Feng, To treat or not to treat: the case of tuberculosis, J. Math. Biol., 35 (1997), 629–656. https://doi.org/10.1007/s002850050069 doi: 10.1007/s002850050069
    [15] Z. Feng, C. Castillo-Chavez, A. Capurro, A model for tuberculosis with exogenous reinfection, Theor. Popul. Biol., 57 (2000), 235–247. https://doi.org/10.1006/tpbi.2000.1451 doi: 10.1006/tpbi.2000.1451
    [16] A. Ssematimba, J. Mugisha, L. Luboobi, Mathematical models for the dynamics of tuberculosis in density-dependent populations: The case of internally displaced peoples' camps (IDPCs) in Uganda, J. Math. Stat., 1 (2005), 217–224. https://doi.org/10.3844/jmssp.2005.217.224 doi: 10.3844/jmssp.2005.217.224
    [17] B. Song, C. Castillo-Chavez, J. Aparicio, Global dynamics of tuberculosis models with density dependent demography, in Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods, and Theory, Springer, (2002), 275–294. https://doi.org/10.1007/978-1-4613-0065-6
    [18] E. Ziv, C. Daley, S. Blower, Early therapy for latent tuberculosis infection, Am. J. Epidemiol., 153 (2001), 381–385. https://doi.org/10.1093/aje/153.4.381 doi: 10.1093/aje/153.4.381
    [19] F. Agusto, J. Cook, P. Shelton, M. Wickers, Mathematical model of MDR-TB and XDR-TB with isolation and lost to follow-up, Abstr. Appl. Anal., 2015 (2015). https://doi.org/10.1155/2015/828461 doi: 10.1155/2015/828461
    [20] L. Liu, Y. Wang, A mathematical study of a TB model with treatment interruptions and two latent periods, Comput. Math. Methods Med., 2014 (2014). https://doi.org/10.1155/2014/932186 doi: 10.1155/2014/932186
    [21] L. Liu, Y. Wang, Analysis of a TB model with treatment interruptions, J. Nonlinear Sci. Appl., 9 (2016), 1549–1563. https://doi.org/10.22436/jnsa.009.04.13 doi: 10.22436/jnsa.009.04.13
    [22] D. Moualeu, A. Yakam, S. Bowong, A. Temgoua, Analysis of a tuberculosis model with undetected and lost-sight cases, Commun. Nonlinear Sci. Numer. Simul., 41 (2016), 48–63. https://doi.org/10.1016/j.cnsns.2016.04.012 doi: 10.1016/j.cnsns.2016.04.012
    [23] D. Setyorini, B. Handari, D. Aldila, Numerical analysis of the impact of loss-sight and undetected cases in the spread of TB, in AIP Conference Proceedings, 2084 (2019), 020019. https://doi.org/10.1063/1.5094283
    [24] Y. Emvudu, R. Demasse, D. Djeudeu, Optimal control of the lost to follow up in a tuberculosis model, Comput. Math. Methods Med., 2011 2011. https://doi.org/10.1155/2011/398476 doi: 10.1155/2011/398476
    [25] M. Bates, Y. Ahmed, N. Kapata, M. Maeurer, P. Mwaba, A. Zumla, Perspectives on tuberculosis in pregnancy, Int. J. Infect. Dis., 32 (2015), 124–127. https://doi.org/10.1016/j.ijid.2014.12.014 doi: 10.1016/j.ijid.2014.12.014
    [26] S. Fitzwater, L. Caviedes, R. Gilman, J. Coronel, D. LaChira, C. Salazar, et al., Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy, Clin. Infect. Dis., 51 (2010), 371–378. https://doi.org/10.1086/655127 doi: 10.1086/655127
    [27] J. Liu, T. Zhang, Global stability for a tuberculosis model, Math. Comput. Modell., 54 (2011), 836–845. https://doi.org/10.1016/j.mcm.2011.03.033 doi: 10.1016/j.mcm.2011.03.033
    [28] J. Trauer, J. Denholm, E. McBryde, Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific, J. Theor. Biol., 358 (2014), 74–84. https://doi.org/10.1016/j.jtbi.2014.05.023 doi: 10.1016/j.jtbi.2014.05.023
    [29] M. Martcheva, An introduction to mathematical epidemiology, in Texts in Applied Mathematics, Springer Science & Business Media, 61 (2015). https://doi.org/10.1007/978-1-4899-7612-3
    [30] P. van den Driessche, J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci., 180 (2002), 29–48. https://doi.org/10.1016/S0025-5564(02)00108-6 doi: 10.1016/S0025-5564(02)00108-6
    [31] C. Castillo-Chavez, Z. Feng, W. Huang, On the computation of R0 and its role on global stability, in Mathematical Approaches for Emerging and Re-Emerging Infection Diseases: An Introduction, Springer-Verlag, 125 (2002), 229–250. https://doi.org/10.1007/978-1-4757-3667-0_13
    [32] P. Waltman, A Second Course in Elementary Differential Equations, Academic Press, 1986. https://doi.org/10.1016/B978-0-12-733910-8.50005-3
    [33] B. Goh, Management and analysis of biological populations, in Developments in Agricultural and Managed Forest Ecology, Elsevier Science Ltd., 9 (1980).
    [34] C. McCluskey, Lyapunov functions for tuberculosis models with fast and slow progression, Math. Biosci. Eng., 3 (2006), 603–614. https://doi.org/10.3934/mbe.2006.3.603 doi: 10.3934/mbe.2006.3.603
    [35] B. J. Venkatachala, Inequalities: An approach through problems, in Texts and Readings in Mathematics, Springer, 49 (2018). https://doi.org/10.1007/978-981-10-8732-5
    [36] Y. Yang, S. Tang, X. Ren, H. Zhao, C. Guo, Global stability and optimal control for a tuberculosis model with vaccination and treatment, Discrete Contin. Dyn. Syst. B, 21 (2016), 1009–1022. https://doi.org/10.3934/dcdsb.2016.21.1009 doi: 10.3934/dcdsb.2016.21.1009
    [37] D. Gao, N. Huang, Optimal control analysis of a tuberculosis model, Appl. Math. Modell., 58 (2018), 47–64. https://doi.org/10.1016/j.apm.2017.12.027 doi: 10.1016/j.apm.2017.12.027
    [38] M. Gomes, P. Rodrigues, F. Hilker, N. Mantilla-Beniers, M. Muehlen, A. Paulo, et al., Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions, J. Theor. Biol., 248 (2007), 608–617. https://doi.org/10.1016/j.jtbi.2007.06.005 doi: 10.1016/j.jtbi.2007.06.005
    [39] R. Hickson, G. Mercer, K. Lokuge, A metapopulation model of tuberculosis transmission with a case study from high to low burden areas, PLoS One, 7 (2012), e3441. https://doi.org/10.1371/journal.pone.0034411 doi: 10.1371/journal.pone.0034411
    [40] M. Renardy, D. E. Kirschner, A framework for network-based epidemiological modeling of tuberculosis dynamics using synthetic datasets, Bull. Math. Biol., 82 (2020), 1–20. https://doi.org/10.1007/s11538-020-00752-9 doi: 10.1007/s11538-020-00752-9
    [41] E. Barrios, S. Lee, O. Vasilieva, Assessing the effects of daily commuting in two-patch dengue dynamics: A case study of Cali, Colombia, J. Theor. Biol., 453 (2018), 14–39. https://doi.org/10.1016/j.jtbi.2018.05.015 doi: 10.1016/j.jtbi.2018.05.015
  • This article has been cited by:

    1. Na Pang, Nonlinear neural networks adaptive control for a class of fractional-order tuberculosis model, 2023, 20, 1551-0018, 10464, 10.3934/mbe.2023461
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2247) PDF downloads(117) Cited by(1)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog